Form 4: Ormat Director Sells Shares in Pre-Planned Transaction
Insider Transaction Report
Ormat Technologies Director Stanley Stern sold 876 shares of common stock for $91.985 per share in a pre-planned transaction.
Summary
- Stanley Stern, a Director at Ormat Technologies, Inc. (ORA), disposed of 876 shares of common stock.
- The transaction occurred on August 27, 2025, at a price of $91.985 per share.
- Following the sale, Mr. Stern directly owns 5,261 shares of Ormat Technologies common stock.
- The sale was conducted under a Rule 10b5-1(c) pre-arranged trading plan, indicating a scheduled transaction.
Sentiment
Score: 5
Explanation: The filing reports a routine insider sale under a Rule 10b5-1 plan, which is generally considered a neutral event as it reflects a pre-scheduled transaction rather than a discretionary sale based on new material information.
Industry Context
This insider transaction report does not provide direct insights into broader industry trends or competitive positioning. It is a routine disclosure of a director's stock sale.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Policy Adherence | The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). | 08/27/2025 | Indicates adherence to insider trading policies and pre-planned stock sales, which helps mitigate concerns about opportunistic trading based on non-public information. |
Stakeholder Impact
- Shareholders: A director's sale of shares, even under a pre-planned 10b5-1 arrangement, is a routine disclosure. The pre-planned nature generally reduces concerns that the sale is based on new, negative material information, thus the impact on shareholder sentiment is typically minimal.
Key Dates
| Date | Description |
|---|---|
| 08/27/2025 | Date of earliest transaction (sale of common stock) |
| 08/29/2025 | Date Form 4 was filed with the SEC |
Recommendation
holdThe filing details a pre-planned sale of a relatively small number of shares by a director under a Rule 10b5-1 plan. Such transactions are generally considered routine and do not typically signal a change in the company's fundamental outlook or warrant an immediate change in investment recommendation. Investors should continue to monitor broader company performance and market conditions.
Keywords
Ormat Technologies, ORA, Stanley Stern, Insider Trading, Form 4, Director Sale, Stock Sale, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.